Theravance Biopharma Inc

NASDAQ:TBPH   12:11:09 PM EDT
10.17
+0.15 (+1.50%)
Share Repurchases, Earnings Announcements

Theravance Biopharma Initiates $250 Mln Capital Return Program

Published: 09/19/2022 10:19 GMT
Theravance Biopharma Inc (TBPH) - Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program.
Theravance Biopharma Inc - Agreed to Purchase Gsk's Entire Holdings at $9.75 per Share.
Theravance Biopharma Inc - Plans to Launch a Dutch Auction Tender Offer in Near Term to Purchase Approximately $95 Million of Its Ordinary Shares.
Theravance Biopharma Inc - Plans to Enter Into an Open Market Share Repurchase Plan Subsequent to Tender Offer Utilizing Additional About $60 Million.
Revenue is expected to be $11.56 Million
Adjusted EPS is expected to be -$0.13

Next Quarter Revenue Guidance is expected to be $12.32 Million
Next Quarter EPS Guidance is expected to be -$0.09

More details on our Analysts Page.